Fatigue-resistant flow regulating device and manufacturing methods

• US 9,801,737 B2
• Filed: 03/09/2011
• Issued: 10/31/2017
• Est. Priority Date: 03/17/2010
• Status: Active Grant

• Current Assignee: Deep Vein Medical, Inc.
• Original Assignee: Deep Vein Medical, Inc.
• Inventors: Hinchliffe, Peter W. J., Kalmann, Menno, Lehman, Adam I., Laksin, Olga
• Primary Examiner(s): Prone, Christopher D
• Assistant Examiner(s): Diop, Rokhaya
• Application Number:
  US13/635,589
• Publication Number:
  US 20130123908A1
• Time in Patent Office: 2,428 Days
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2/82 Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95; for closing wounds, or holding wounds closed A61B17/04 - A61B17/115; dilators A61M29/00
• CPC Class Codes: A61L 2400/16 Materials with shape-memory or superelastic properties
• CPC Class Codes: A61L 27/047 Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
• CPC Class Codes: A61L 27/48 with macromolecular fillers
• CPC Class Codes: C08L 27/18 Homopolymers or copolymers or tetrafluoroethene
• CPC Class Codes: C08L 75/04 Polyurethanes
• CPC Class Codes: Y10T 156/1051 by folding

Abstract

The subject invention is directed to devices and methods for producing devices for regulating blood flow in the venous system. In particular, the invention provides for artificial valves designed to regulate the flow of blood in human vessels, wherein such artificial valves include superior properties including fatigue resistance, biocompatibility, and ease of manufacture.

Claims

1. An implantable device for regulating blood flow through a blood vessel, comprising:

a) an elongated support dimensioned and configured to be implanted in a blood vessel, the support including axially spaced-apart first and second annular ring portions sharing a common longitudinal axis, and a linking member linking the axially spaced-apart first and second annular ring portions to one another, wherein the linking member comprises first and second connecting members each having a first end connected to the first annular ring portion and a second end connected to the second annular ring portion, wherein the first ends of the first and second connecting members extend from and share a common point of the first annular ring portion and the second ends of the first and second connecting members extend from separate points of the second annular ring portion, wherein the separate points of the second annular ring portion are approximately 160 degrees out of phase from the common point of the first annular ring portion relative to the common longitudinal axis such that the linking member is configured to extend in a direction from the first ends of the first and second connecting members to the second ends of the first and second connecting members across a diameter of the blood vessel when the device is implanted therein;

b) a valve membrane extending between the axially spaced-apart first and second annular ring portions, the valve membrane having an upper portion connected to a portion of the first annular ring portion, a lower portion coupled to a portion of the second annular ring portion, and an intermediate portion there between, the valve membrane including a first region, a second region, and a flap adjacent the first region, the flap folded over the linking member for attachment of the valve membrane to the linking member and the second region being adjacent the first region and unattached to the linking member, the second region movable between a first position to enable blood flow and a second position to inhibit blood flow, wherein at least one of the flap and the first region includes an impregnation material therein, and wherein the flap is joined to the first region of the valve membrane at a seamless, heat-shaped adhesion region that includes the impregnation material.

2. An implantable device as recited in claim 1, wherein the support is formed at least in part from a one piece Nitinol construct.

3. An implantable device as recited in claim 1, wherein the valve membrane is formed at least in part from ePTFE.

4. An implantable device as recited in claim 1, wherein the impregnation material includes a biocompatible polycarbonate polyurethane material.